A detailed history of State Street Corp transactions in Fulgent Genetics, Inc. stock. As of the latest transaction made, State Street Corp holds 793,545 shares of FLGT stock, worth $14.2 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
793,545
Previous 782,677 1.39%
Holding current value
$14.2 Million
Previous $15.4 Million 12.24%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$19.6 - $25.06 $213,012 - $272,352
10,868 Added 1.39%
793,545 $17.2 Million
Q2 2024

Aug 14, 2024

SELL
$19.09 - $22.57 $797,962 - $943,426
-41,800 Reduced 5.07%
782,677 $15.4 Million
Q1 2024

May 15, 2024

BUY
$21.55 - $29.29 $248,794 - $338,153
11,545 Added 1.42%
824,477 $17.9 Million
Q4 2023

Feb 14, 2024

BUY
$23.64 - $30.27 $965,835 - $1.24 Million
40,856 Added 5.29%
812,932 $23.5 Million
Q3 2023

Nov 14, 2023

BUY
$26.74 - $40.81 $425,567 - $649,491
15,915 Added 2.1%
772,076 $20.6 Million
Q2 2023

Aug 14, 2023

SELL
$28.52 - $40.7 $1.22 Million - $1.75 Million
-42,920 Reduced 5.37%
756,161 $28 Million
Q1 2023

May 15, 2023

SELL
$29.39 - $36.27 $205,553 - $253,672
-6,994 Reduced 0.87%
799,081 $24.9 Million
Q4 2022

Feb 14, 2023

BUY
$29.23 - $40.28 $1.45 Million - $2 Million
49,718 Added 6.57%
806,075 $24 Million
Q3 2022

Nov 15, 2022

BUY
$37.92 - $63.74 $1.45 Million - $2.43 Million
38,121 Added 5.31%
756,357 $28.8 Million
Q2 2022

Aug 15, 2022

BUY
$47.98 - $62.75 $1.06 Million - $1.39 Million
22,153 Added 3.18%
718,236 $39.2 Million
Q1 2022

May 16, 2022

BUY
$49.85 - $96.11 $3.53 Million - $6.8 Million
70,764 Added 11.32%
696,083 $43.4 Million
Q4 2021

Feb 14, 2022

BUY
$77.3 - $105.0 $291,266 - $395,640
3,768 Added 0.61%
625,319 $62.9 Million
Q3 2021

Nov 15, 2021

BUY
$74.87 - $110.87 $926,291 - $1.37 Million
12,372 Added 2.03%
621,551 $55.9 Million
Q2 2021

Aug 16, 2021

BUY
$66.8 - $100.45 $10 Million - $15.1 Million
150,062 Added 32.68%
609,179 $56.2 Million
Q1 2021

May 17, 2021

BUY
$59.3 - $183.85 $2.8 Million - $8.69 Million
47,260 Added 11.47%
459,117 $44.4 Million
Q4 2020

Feb 16, 2021

BUY
$31.01 - $52.1 $4.53 Million - $7.62 Million
146,193 Added 55.03%
411,857 $21.5 Million
Q3 2020

Nov 10, 2020

BUY
$15.89 - $50.51 $2.08 Million - $6.61 Million
130,881 Added 97.1%
265,664 $10.6 Million
Q2 2020

Aug 14, 2020

BUY
$8.89 - $18.28 $1.2 Million - $2.46 Million
134,783 New
134,783 $2.16 Million

Others Institutions Holding FLGT

About Fulgent Genetics, Inc.


  • Ticker FLGT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 30,265,800
  • Market Cap $541M
  • Description
  • Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...
More about FLGT
Track This Portfolio

Track State Street Corp Portfolio

Follow State Street Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.